Structure |
Chemical Name |
CAS |
MF |
|
Cetrorelix Impurity 18 |
|
|
|
Cetrorelix Impurity 13 |
|
|
|
NA |
|
|
|
Imatinib Impurity 1 |
|
|
|
Cetrorelix Impurity 2 (+L-Ser) |
|
|
|
Imatinib Impurity 6 |
|
|
|
Peramivir Intermediate Impurity 39 |
|
|
|
Nifedipine Impurity 3 |
|
C19H22N2O6 |
|
Peramivir Intermediate Impurity 59 |
|
|
|
Riociguat Impurtiy 5 |
|
|
|
Criborole impurity 999 |
|
|
|
Vonoprazan Impurity 6 |
|
|
|
NA |
|
|
|
Citalopram EP Impurity E |
64169-47-7 |
C19H22Cl2FNO |
|
Bimatoprost Impurity 2 |
|
|
|
Dapagliflozin Impurity F |
|
|
|
Dapoxetine Impurity A |
|
|
|
(1R,3S,4S)-エンテカビル |
1333204-94-6 |
C12H15N5O3 |
|
Pregna-1,4-dien-3-one, 21-(acetyloxy)-11,17,20-trihydroxy-6-methyl-, (6α,11β)- (9CI) |
151003-82-6 |
C24H34O6 |
|
3-[4-(トリフルオロメチル)フェニル]プロパン-1-オール |
180635-74-9 |
C10H11F3O |
|
(1R,2R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
|
|
|
(E)-2-CYANO-5-METHYL-HEX-2-ENOIC ACID METHYL ESTER |
96914-67-9 |
C9H13NO2 |
|
Nicergoline Impurity 7 |
|
|
|
N,N'-Bis(2-Hydroxyethyl)propane-1,3-diamine |
10563-27-6 |
C7H18N2O2 |
|
4-((3-hydroxy-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
|
2-oxo-2-((6S,8S,9S,10R,13S,14S,17S)-6,10,13-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate |
|
|
|
Tirofiban Impurity 79 |
158808-85-6 |
C21H34N2O5S |
|
Brivaracetam Impurity 47 |
2755924-55-9 |
|
|
4-((3-amino-1-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
|
2-[(Z)-シアノ(2,3-ジクロロフェニル)メチレン]ヒドラジンカルボイミドアミド |
94213-23-7 |
C9H7Cl2N5 |
|
Perampanel Impurity ABCDEFGHJKL |
|
|
|
2-クロロ-1-(4,5-ジクロロ-2-チエニル)エタン-1-オン |
64218-50-4 |
C6H3Cl3OS |
|
Gadobutrol Impurity |
|
|
|
Pramipexole Impurity G |
|
|
|
SALMETEROL RELATED COMPOUND A (4-[1-ヒドロキシ-2-(4-フェニルブチルアミノ)エチル]-2-(ヒドロキシメチル)フェノール) |
1798014-51-3 |
C19H25NO3 |
|
Tacrolimus impurity D |
|
|
|
2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole |
202189-77-3 |
C32H44N4O2 |
|
Saxagliptin Impurity 6 |
|
|
|
Ethyl 4-(4-fluorophenyl)-1-methyl-2,6-dioxopiperidine-3-carboxylate |
202534-94-9 |
C15H16FNO4 |
|
Tofacitinib Impurity 100 |
|
|
|
Vildagliptin Impurity 36 |
|
|
|
Butyphthalide impurity 52 |
|
|
|
Tofacitinib Impurity 102 |
1615709-90-4 |
C14H17ClN2 |
|
Pralatrexate Impurity 12 |
1451250-74-0 |
C23H23N7O5 |
|
Pralatrexate Impurity 17 |
|
|
|
Pitavastatin Impurity 49 |
|
|
|
Pitavastatin Impurity 55 |
|
|
|
Lenvatinib Impurity 40 |
|
|
|
Tazobactam Impurity 11 |
|
|
|
Crisaborole Impurity 2 |
|
|
|
Canagliflozin Impurity 58 |
|
|
|
Canagliflozin Impurity 63 |
|
|
|
Levetiracetam Impurity 23 |
|
|
|
Selexipag Impurity 4 |
2928611-77-0 |
|
|
3H-4,7a-Methanocyclohept[3,3a]indeno[5,4-b]oxete Benzenepropanoic Acid Derivative |
146139-03-9 |
C47H51NO14 |
|
Fluvastatin 3-Hydroxy-4,6-diene |
1207963-21-0 |
C24H24FNO3 |
|
Cyclosporine iMpurity |
|
|
|
ThiaMine IMpurity |
|
C12H17ClN4OS |
|
CitalopraM IMpurity |
|
|
|
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
|
C16H14N2O3S |
|
Tigecycline |
|
|
|
1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
1496551-72-4 |
C10H13ClN2O5 |
|
1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)- |
1020414-33-8 |
C22H25ClF3N |
|
4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine |
1823431-32-8 |
C7H9Cl2N3OS |
|
Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester |
866551-95-3 |
C20H27NO7 |
|
4',6'-Dinitro-2'-phenoxymethanesulfonanilide |
51765-56-1 |
C13H11N3O7S |
|
5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride |
33778-93-7 |
C20H26ClNO4 |
|
(5Z,7E)-9,10-セコ-26,27-シクロ-1α,3β-ジヒドロキシコレスタ-5,7,10(19)-トリエン-24-オン |
126860-84-2 |
C27H40O3 |
|
(S)-7-アセチルアミノ-6,7-ジヒドロ-3-ヒドロキシ-1,2,10-トリメトキシベンゾ[a]ヘプタレン-9(5H)-オン |
7336-33-6 |
C21H23NO6 |
|
2-[4-(4-クロロベンゾイル)フェノキシ]-2-メチルプロパン酸メチル |
42019-07-8 |
C18H17ClO4 |
|
1,3-ジメチル-5,5-ジ(2-プロペニル)ピリミジン-2,4,6(1H,3H,5H)-トリオン |
722-97-4 |
C12H16N2O3 |
|
9-[[(2E)-4-[[(2S,3R,4R,5S)-3α,4α-ジヒドロキシ-5β-[(2E,4S,5S)-5-ヒドロキシ-4-メチル-2-ヘキセニル]テトラヒドロ-2H-ピラン]-2β-イル]-3-メチル-2-ブテノイル]オキシ]ノナン酸 |
71980-98-8 |
C26H44O8 |
|
D,L-O-DesMethyl Venlafaxine-d6 |
1062605-69-9 |
C16H19D6NO2 |
|
(E)-3-[p-ブロモメチルフェニル]アクリル酸エチル |
78712-67-1 |
C12H13BrO2 |
|
3-アミノ-2-ブテン酸 |
21112-45-8 |
C4H7NO2 |
|
Levosimendan Impurity 10 |
134678-47-0 |
C11H12N2O2 |
|
Cabozantinib impurity I |
|
|
|
Rotigotine Impurity 2 |
|
|
|
Rotigotine Impurity 9 |
|
|
|
Olprinone Impurity 5 |
|
|
|
Vitamin B5 Impurity 1 |
897045-90-8 |
C12H22N2O6 |
|
Cilastatin Impurity 5 |
|
|
|
(R)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)tetrahydrofuran |
2194590-02-6 |
C17H16ClIO2 |
|
Sitagliptin Impurity 69 |
2172430-88-3 |
C15H16F3NO4 |
|
Trimetazidine Impurity 8 |
|
|
|
MeropeneM iMpurity 5 |
|
|
|
Perindopril IMpurity 6 |
2163775-15-1 |
C8H15NO4 |
|
Oseltamivir Impurity 48 |
651324-04-8 |
C18H33NO4 |
|
Tamsulosin impurity 5 |
|
C20H28N2O5S |
|
Flucloxacillin Impurity 5 |
|
|
|
Nitrendipine iMpurity G |
|
|
|
(S)-N-(5-((S)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
2409589-59-7 |
C21H22F2N6O2 |
|
Empagliflozin Impurity 61 |
|
|
|
Ipragliflozin Impurity 3 |
|
|
|
Isavuconazole Impurity 30 |
|
|
|
Levetiracetam Impurity 27 |
|
|
|
Linagliptin Impurity 58 |
|
|
|
Oseltamivir Impurity 33 |
|
|
|
Oseltamivir Impurity 49 |
|
|
|
Palbociclib Impurity 52 |
|
|